Literature DB >> 21530680

Use of a precious resource: parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetes.

Kimberly A Driscoll1, Suzanne Bennett Johnson, Desmond A Schatz, Michael J Haller.   

Abstract

OBJECTIVE: To assess parental decision making and experiences in an autologous umbilical cord blood infusion study in young children with type 1 diabetes (T1D).
METHODS: Surveys were completed with 22 parents of children with T1D who received infusion and 22 parents who declined infusion.
RESULTS: Parents who stored umbilical cord blood were middle-aged, highly-educated, Caucasian, married, and privately insured. Parents of children who did not receive infusion declined because they did not want to deplete their cord blood supply. Parents of children who decided to have their children participate in the infusion study were similar on approaches to storing cord blood and attitudes about research as compared to parents who declined to have their children participate in the infusion. Parents of children who received infusion were positive about their experiences and held expectations that infusion would lead to a T1D cure.
CONCLUSIONS: The manner in which cord blood is stored needs to be considered so that participation in future studies does not risk depletion of the cord blood supply. In addition, it appears that the process of storing umbilical cord blood leads to restricted demographic characteristics of eligible participants, which may impact recruitment in clinical trials. These results are relevant to designing future cord blood studies in T1D and other non-malignant diseases.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530680      PMCID: PMC3129744          DOI: 10.1016/j.cct.2011.04.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  14 in total

Review 1.  Umbilical cord stem cells.

Authors:  Kenneth J Moise
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

2.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

3.  Umbilical cord blood and type 1 diabetes: A road ahead or dead end?

Authors:  David Bleich
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 4.  Autologous umbilical cord blood infusion for type 1 diabetes.

Authors:  Michael J Haller; Hilla-Lee Viener; Clive Wasserfall; Todd Brusko; Mark A Atkinson; Desmond A Schatz
Journal:  Exp Hematol       Date:  2008-03-20       Impact factor: 3.084

5.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

6.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

Authors:  Susan L Staba; Maria L Escolar; Michele Poe; Young Kim; Paul L Martin; Paul Szabolcs; June Allison-Thacker; Susan Wood; David A Wenger; Pablo Rubinstein; John J Hopwood; William Krivit; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

7.  Umbilical cord blood collection: do patients really understand?

Authors:  Nathan S Fox; Cladd Stevens; Rodica Ciubotariu; Pablo Rubinstein; Laurence B McCullough; Frank A Chervenak
Journal:  J Perinat Med       Date:  2007       Impact factor: 1.901

8.  C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Authors:  Carlos E B Couri; Maria C B Oliveira; Ana B P L Stracieri; Daniela A Moraes; Fabiano Pieroni; George M N Barros; Maria Isabel A Madeira; Kelen C R Malmegrim; Maria C Foss-Freitas; Belinda P Simões; Edson Z Martinez; Milton C Foss; Richard K Burt; Júlio C Voltarelli
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

9.  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Authors:  Júlio C Voltarelli; Carlos E B Couri; Ana B P L Stracieri; Maria C Oliveira; Daniela A Moraes; Fabiano Pieroni; Marina Coutinho; Kelen C R Malmegrim; Maria C Foss-Freitas; Belinda P Simões; Milton C Foss; Elizabeth Squiers; Richard K Burt
Journal:  JAMA       Date:  2007-04-11       Impact factor: 56.272

10.  Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians.

Authors:  Ian Thornley; Mary Eapen; Lillian Sung; Stephanie J Lee; Stella M Davies; Steven Joffe
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

View more
  2 in total

1.  Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.

Authors:  Michael J Haller; Clive H Wasserfall; Maigan A Hulme; Miriam Cintron; Todd M Brusko; Keiran M McGrail; John R Wingard; Douglas W Theriaque; Jonathan J Shuster; Ronald J Ferguson; Marianne Kozuch; Michael Clare-Salzler; Mark A Atkinson; Desmond A Schatz
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-20       Impact factor: 5.742

2.  Developing a survey of barriers and facilitators to recruitment in randomized controlled trials.

Authors:  Geetinder Kaur; Rosalind L Smyth; Paula Williamson
Journal:  Trials       Date:  2012-11-21       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.